Humacyte, Inc.

HUMA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$149-$111-$12-$26
Dep. & Amort.$7$8$8$8
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$0$6$10
Change in WC$0$7$1-$1
Other Non-Cash$37$23-$75-$73
Operating Cash Flow-$98-$73-$71-$81
Investing Activities
PP&E Inv.-$2-$2-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$10-$8
Inv. Sales/Matur.$0$2$16$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$2-$0$5-$8
Financing Activities
Debt Repay.-$3$6-$2$28
Stock Issued$46$1$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$71-$2$1$239
Financing Cash Flow$114$5-$1$267
Forex Effect$0-$0$0$0
Net Chg. in Cash$14-$69-$68$178
Supplemental Information
Beg. Cash$81$150$218$40
End Cash$95$81$150$218
Free Cash Flow-$100-$76-$72-$81